Mammoth Biosciences - Latest News and Information
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Technology Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
HomeMammoth Biosciences
Mammoth Biosciences logo

Mammoth Biosciences

0 followers

About Mammoth Biosciences

Mammoth Biosciences is a biotechnology company focused on gene editing and diagnostics using CRISPR-based technologies. It develops in vivo gene editing therapeutics and CRISPR-based diagnostic solutions, leveraging its protein discovery and engineering platform to advance genetic medicines. The company highlights its work in delivering permanent cures through precise genome editing and offers technologies that address delivery challenges in vivo. Headquartered in the San Francisco Bay Area, Mammoth Biosciences collaborates with researchers and industry partners to transform patient outcomes.

Recent News

No recent news for this company.

Recent Deals

No recent deals for this company.

Key Team Members

Elaine Sun

Chief Financial Officer and Chief Operating Officer

Janice Chen

Co-founder, Chief Technology Officer

Trevor Martin

Co-founder, Chief Executive Officer

Siang Chin

General Counsel and Head of Alliance Management

Lucas Harrington

Co-founder

Key Facts

HQ Location

Brisbane, United States

Founded

2017

Employees

51 - 200

Status

Private

Website

https://mammoth.bio